Ako J - Search Results

1

Neoatherosclerosis 16 years following bare-metal stent implantation: different tissue components in different underlying lesions observed with optical coherence tomography.

Hashikata T, Tojo T, Ishii S, Kitasato L, Kameda R, Shimohama T, Yamaoka-Tojo M, Ako J. Hashikata T, et al. Among authors: ako j. Int J Cardiol. 2013 Dec 5;170(1):e8-10. doi: 10.1016/j.ijcard.2013.10.054. Int J Cardiol. 2013. PMID: 24383068 No abstract available.

2

Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results.

Grube E, Sievert H, Hauptmann KE, Mueller R, Gerckens U, Buellesfeld L, Ako J, Shimohama T, Costa M, Fitzgerald P. Grube E, et al. Among authors: ako j. EuroIntervention. 2008 May;4(1):71-6. doi: 10.4244/eijv4i1a13. EuroIntervention. 2008. PMID: 19112782 Clinical Trial.

3

Incidence of diffuse and focal chronic stent recoil after implantation of current generation bare-metal and drug-eluting stents.

Koo BK, Waseda K, Ako J, Hasegawa T, Shimohama T, Nakatani D, Otake H, Yamasaki M, Sakurai R, Tsujino I, Honda Y, Fitzgerald PJ. Koo BK, et al. Among authors: ako j. Int J Cardiol. 2010 Sep 24;144(1):132-4. doi: 10.1016/j.ijcard.2008.12.117. Epub 2009 Jan 26. Int J Cardiol. 2010. PMID: 19171393 No abstract available.

4

Preprocedural inflammation does not affect neointimal hyperplasia following everolimus-eluting stent implantation.

Nakatani D, Ako J, Yamasaki M, Shimohama T, Hasegawa T, Otake H, Waseda K, Tsujino I, Sakurai R, Koo BK, Chang H, Yock PG, Sudhir K, Pierson W, Stone GW, Saito S, Honda Y, Fitzgerald PJ. Nakatani D, et al. Among authors: ako j. J Invasive Cardiol. 2009 Dec;21(12):613-7. J Invasive Cardiol. 2009. PMID: 19966361 Free article.

5

SPIRIT III JAPAN versus SPIRIT III USA: a comparative intravascular ultrasound analysis of the everolimus-eluting stent.

Shimohama T, Ako J, Yamasaki M, Otake H, Tsujino I, Hasegawa T, Nakatani D, Sakurai R, Chang H, Kusano H, Waseda K, Honda Y, Stone GW, Saito S, Fitzgerald PJ, Sudhir K. Shimohama T, et al. Among authors: ako j. Am J Cardiol. 2010 Jul 1;106(1):13-7. doi: 10.1016/j.amjcard.2010.02.008. Am J Cardiol. 2010. PMID: 20609640

6

Comparison of everolimus- versus paclitaxel-eluting stents implanted in patients with diabetes mellitus as evaluated by three-dimensional intravascular ultrasound analysis.

Otake H, Ako J, Yamasaki M, Tsujino I, Shimohama T, Hasegawa T, Sakurai R, Waseda K, Honda Y, Sood P, Sudhir K, Stone GW, Fitzgerald PJ. Otake H, et al. Among authors: ako j. Am J Cardiol. 2010 Aug 15;106(4):492-7. doi: 10.1016/j.amjcard.2010.03.059. Am J Cardiol. 2010. PMID: 20691306 Clinical Trial.

7

Evaluation of the peri-strut low intensity area following sirolimus- and paclitaxel-eluting stents implantation: insights from an optical coherence tomography study in humans.

Otake H, Shite J, Ikeno F, Shinke T, Teramoto T, Miyoshi N, Ako J, Honda Y, Fitzgerald PJ, Hirata K. Otake H, et al. Among authors: ako j. Int J Cardiol. 2012 May 17;157(1):38-42. doi: 10.1016/j.ijcard.2010.11.006. Epub 2010 Dec 18. Int J Cardiol. 2012. PMID: 21168926

8

Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions.

Otake H, Honda Y, Courtney BK, Shimohama T, Ako J, Waseda K, Macours N, Rogers C, Popma JJ, Abizaid A, Ormiston JA, Spaulding C, Cohen SA, Fitzgerald PJ. Otake H, et al. Among authors: ako j. Circ Cardiovasc Interv. 2011 Apr 1;4(2):146-54. doi: 10.1161/CIRCINTERVENTIONS.110.957175. Epub 2011 Mar 8. Circ Cardiovasc Interv. 2011. PMID: 21386089 Clinical Trial.

9

Intravascular ultrasound assessment of postprocedural incomplete stent apposition.

Kume T, Waseda K, Ako J, Sakata K, Yamasaki M, Shimohama T, Tsujino I, Hasegawa T, Fitzgerald PJ, Honda Y. Kume T, et al. Among authors: ako j. J Invasive Cardiol. 2012 Jan;24(1):13-6. J Invasive Cardiol. 2012. PMID: 22210583

10

Intravascular ultrasound insights from the Cobalt Chromium Stent With Antiproliferative for Restenosis II (COSTAR II) trial comparing CoStar and Taxus paclitaxel-eluting stents.

Tsujino I, Koizumi T, Shimohama T, Ako J, Waseda K, Krucoff M, Honda Y, Fitzgerald PJ. Tsujino I, et al. Among authors: ako j. Cardiovasc Revasc Med. 2012 Mar-Apr;13(2):111-8. doi: 10.1016/j.carrev.2012.01.010. Epub 2012 Mar 8. Cardiovasc Revasc Med. 2012. PMID: 22406056 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

622 results

Search Page

Filters